The fight against the COVID-19 pandemic: Vaccination challenges in Sudan

The first COVID-19 case in Sudan was announced on March 13th, 2020. 1835 deaths were recorded as of February 7th, 2021. 800,000 doses of the Oxford-AstraZeneca vaccine were allocated to Sudan through COVAX in March 2021. However, multiple challenges exist in vaccinating the Sudanese population, rang...

Full description

Saved in:

Bibliographic Details
Published in:	Public health in practice (Oxford, England) Vol. 2; p. 100205
Main Authors:	Musa, Mohamed Babiker, Osman Elmahi, Osman Kamal, Modber, Mohamed Abdul Kareem Adam, Abuelgasim Mohammed Yagoub, Fatima Elbasri, Elkabashi Dafallah, Alaa Abusufian, Musa, Shuaibu Saidu, Kangwerema, Allan, Nzeribe, Emmanuella, Mohamed, Alanood Elnaeem, Mohamed, Nora Alnaeem, Ullah, Irfan, Lucero-Prisno, Don Eliseo
Format:	Journal Article
Language:	English
Published:	Elsevier Ltd 01-11-2021 Elsevier
Subjects:	COVAX COVID-19 Oxford-AstraZeneca Sudan COVID-19 COVAX Oxford-AstraZeneca Sudan
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Summary:	The first COVID-19 case in Sudan was announced on March 13th, 2020. 1835 deaths were recorded as of February 7th, 2021. 800,000 doses of the Oxford-AstraZeneca vaccine were allocated to Sudan through COVAX in March 2021. However, multiple challenges exist in vaccinating the Sudanese population, ranging from an inadequate cold chain system to low acceptance rates of COVID-19 vaccination among the Sudanese population. Economic crises, high inflation rates and long-standing economic sanctions have also negatively impacted the healthcare system in Sudan as a result of deprivation of access to research and development funding.
Bibliography:	ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23
ISSN:	2666-5352 2666-5352
DOI:	10.1016/j.puhip.2021.100205